(S)-((1S,2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol

Catalog No. :
ACDUVK754
CAS No. :
1435-55-8
Molecular Formula :
C20H26N2O2
Molecular Weight :
326.44

IUPAC Name:(S)-((1S,2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol

(S)-((1S,2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$69.00Login to see priceIn stockInquiry
100g97%$251.00Login to see priceIn stockInquiry
500g97%$1002.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-((1S,2R,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
IUPAC Name(S)-((1S,2R,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol
MDL No.MFCD00135599
Molecular FormulaC20H26N2O2
Molecular Weight326.44
SMILES[C@H](O)(C=1C2=C(C=CC(OC)=C2)N=CC1)[C@@]3([N@@]4C[C@H](CC)[C@H](C3)CC4)[H]
InChI KeyLJOQGZACKSYWCH-LHHVKLHASA-N
SynonymACon1_001481 | Hydroconquinine | MFCD00135599 | 4-[(tert-butoxy)carbonyl]-1-[(9H-fluoren-9-ylmethoxy)carbonyl]piperazine-2-carboxylic acid | CCG-267773 | 2-[(tert-butoxycarbonyl)amino]-3-(4-fluorophenyl)propanoic acid | CCG-267774 | MFCD01318456 | DB15300
CAS No.1435-55-8
PubChem CID91503

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACDUVK754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDUVK754 route product structure diagram
    ACDUVK7541435-55-8 In Stock
Inquiry

2. ACDUVK754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDUVK754 route product structure diagram
    ACDUVK7541435-55-8 In Stock
Inquiry

Comments (0)